nodes	percent_of_prediction	percent_of_DWPC	metapath
Lincomycin—Azotaemia—Vismodegib—skin cancer	0.0578	0.0578	CcSEcCtD
Lincomycin—Induration—Imiquimod—skin cancer	0.0363	0.0363	CcSEcCtD
Lincomycin—Anorectal discomfort—Imiquimod—skin cancer	0.0297	0.0297	CcSEcCtD
Lincomycin—Local reaction—Imiquimod—skin cancer	0.0293	0.0293	CcSEcCtD
Lincomycin—Induration—Bleomycin—skin cancer	0.0258	0.0258	CcSEcCtD
Lincomycin—Enterocolitis—Docetaxel—skin cancer	0.0233	0.0233	CcSEcCtD
Lincomycin—Local reaction—Bleomycin—skin cancer	0.0208	0.0208	CcSEcCtD
Lincomycin—Rash pustular—Imiquimod—skin cancer	0.0203	0.0203	CcSEcCtD
Lincomycin—Proteinuria—Imiquimod—skin cancer	0.0185	0.0185	CcSEcCtD
Lincomycin—Protein urine present—Imiquimod—skin cancer	0.0182	0.0182	CcSEcCtD
Lincomycin—Vaginal inflammation—Imiquimod—skin cancer	0.0162	0.0162	CcSEcCtD
Lincomycin—Local reaction—Fluorouracil—skin cancer	0.0162	0.0162	CcSEcCtD
Lincomycin—Vaginal infection—Imiquimod—skin cancer	0.0153	0.0153	CcSEcCtD
Lincomycin—Hepatic function abnormal—Imiquimod—skin cancer	0.0135	0.0135	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Vemurafenib—skin cancer	0.0105	0.0105	CcSEcCtD
Lincomycin—Aplastic anaemia—Dactinomycin—skin cancer	0.0101	0.0101	CcSEcCtD
Lincomycin—Oesophagitis—Dactinomycin—skin cancer	0.00982	0.00982	CcSEcCtD
Lincomycin—Vaginal inflammation—Temozolomide—skin cancer	0.00972	0.00972	CcSEcCtD
Lincomycin—Phlebitis—Bleomycin—skin cancer	0.00971	0.00971	CcSEcCtD
Lincomycin—Pancytopenia—Imiquimod—skin cancer	0.00966	0.00966	CcSEcCtD
Lincomycin—Leukocytosis—Fluorouracil—skin cancer	0.00953	0.00953	CcSEcCtD
Lincomycin—Pain—Vismodegib—skin cancer	0.00939	0.00939	CcSEcCtD
Lincomycin—Vaginal infection—Temozolomide—skin cancer	0.00918	0.00918	CcSEcCtD
Lincomycin—Aplastic anaemia—Temozolomide—skin cancer	0.00913	0.00913	CcSEcCtD
Lincomycin—Phlebitis—Dactinomycin—skin cancer	0.00905	0.00905	CcSEcCtD
Lincomycin—Erythema multiforme—Vemurafenib—skin cancer	0.00903	0.00903	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Imiquimod—skin cancer	0.009	0.009	CcSEcCtD
Lincomycin—Abdominal pain—Vismodegib—skin cancer	0.00868	0.00868	CcSEcCtD
Lincomycin—Oesophagitis—Fluorouracil—skin cancer	0.00818	0.00818	CcSEcCtD
Lincomycin—Thrombophlebitis—Temozolomide—skin cancer	0.00815	0.00815	CcSEcCtD
Lincomycin—Pruritus—Vismodegib—skin cancer	0.00777	0.00777	CcSEcCtD
Lincomycin—Erythema multiforme—Imiquimod—skin cancer	0.0077	0.0077	CcSEcCtD
Lincomycin—Tinnitus—Imiquimod—skin cancer	0.00759	0.00759	CcSEcCtD
Lincomycin—Diarrhoea—Vismodegib—skin cancer	0.00751	0.00751	CcSEcCtD
Lincomycin—Thrombophlebitis—Fluorouracil—skin cancer	0.00751	0.00751	CcSEcCtD
Lincomycin—Liver function test abnormal—Dactinomycin—skin cancer	0.0072	0.0072	CcSEcCtD
Lincomycin—Oliguria—Docetaxel—skin cancer	0.00701	0.00701	CcSEcCtD
Lincomycin—Vomiting—Vismodegib—skin cancer	0.00698	0.00698	CcSEcCtD
Lincomycin—Rash—Vismodegib—skin cancer	0.00692	0.00692	CcSEcCtD
Lincomycin—Dermatitis—Vismodegib—skin cancer	0.00692	0.00692	CcSEcCtD
Lincomycin—Pancytopenia—Bleomycin—skin cancer	0.00687	0.00687	CcSEcCtD
Lincomycin—Dermatitis bullous—Fluorouracil—skin cancer	0.0068	0.0068	CcSEcCtD
Lincomycin—Anaphylactic shock—Vemurafenib—skin cancer	0.00679	0.00679	CcSEcCtD
Lincomycin—Nausea—Vismodegib—skin cancer	0.00652	0.00652	CcSEcCtD
Lincomycin—Angioedema—Imiquimod—skin cancer	0.00648	0.00648	CcSEcCtD
Lincomycin—Pancytopenia—Dactinomycin—skin cancer	0.0064	0.0064	CcSEcCtD
Lincomycin—Hypotension—Vemurafenib—skin cancer	0.00634	0.00634	CcSEcCtD
Lincomycin—Neutropenia—Dactinomycin—skin cancer	0.0063	0.0063	CcSEcCtD
Lincomycin—Stomatitis—Bleomycin—skin cancer	0.00628	0.00628	CcSEcCtD
Lincomycin—Colitis—Docetaxel—skin cancer	0.00621	0.00621	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.00596	0.00596	CcSEcCtD
Lincomycin—Oesophagitis—Docetaxel—skin cancer	0.00591	0.00591	CcSEcCtD
Lincomycin—Stomatitis—Dactinomycin—skin cancer	0.00586	0.00586	CcSEcCtD
Lincomycin—Pancytopenia—Temozolomide—skin cancer	0.00579	0.00579	CcSEcCtD
Lincomycin—Neutropenia—Temozolomide—skin cancer	0.0057	0.0057	CcSEcCtD
Lincomycin—Shock—Imiquimod—skin cancer	0.00569	0.00569	CcSEcCtD
Lincomycin—Agranulocytosis—Dactinomycin—skin cancer	0.00561	0.00561	CcSEcCtD
Lincomycin—Phlebitis—Docetaxel—skin cancer	0.00545	0.00545	CcSEcCtD
Lincomycin—Thrombophlebitis—Docetaxel—skin cancer	0.00542	0.00542	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.00539	0.00539	CcSEcCtD
Lincomycin—Body temperature increased—Vemurafenib—skin cancer	0.00536	0.00536	CcSEcCtD
Lincomycin—Pancytopenia—Fluorouracil—skin cancer	0.00534	0.00534	CcSEcCtD
Lincomycin—Stomatitis—Temozolomide—skin cancer	0.0053	0.0053	CcSEcCtD
Lincomycin—Erythema multiforme—Dactinomycin—skin cancer	0.0051	0.0051	CcSEcCtD
Lincomycin—Hypersensitivity—Vemurafenib—skin cancer	0.005	0.005	CcSEcCtD
Lincomycin—Pain—Imiquimod—skin cancer	0.00495	0.00495	CcSEcCtD
Lincomycin—Dermatitis bullous—Docetaxel—skin cancer	0.00491	0.00491	CcSEcCtD
Lincomycin—Stomatitis—Fluorouracil—skin cancer	0.00488	0.00488	CcSEcCtD
Lincomycin—Pruritus—Vemurafenib—skin cancer	0.0048	0.0048	CcSEcCtD
Lincomycin—Agranulocytosis—Fluorouracil—skin cancer	0.00468	0.00468	CcSEcCtD
Lincomycin—Diarrhoea—Vemurafenib—skin cancer	0.00464	0.00464	CcSEcCtD
Lincomycin—Erythema multiforme—Temozolomide—skin cancer	0.00461	0.00461	CcSEcCtD
Lincomycin—Urticaria—Imiquimod—skin cancer	0.0046	0.0046	CcSEcCtD
Lincomycin—Abdominal pain—Imiquimod—skin cancer	0.00457	0.00457	CcSEcCtD
Lincomycin—Body temperature increased—Imiquimod—skin cancer	0.00457	0.00457	CcSEcCtD
Lincomycin—Tinnitus—Temozolomide—skin cancer	0.00455	0.00455	CcSEcCtD
Lincomycin—Leukopenia—Bleomycin—skin cancer	0.00451	0.00451	CcSEcCtD
Lincomycin—Liver function test abnormal—Docetaxel—skin cancer	0.00433	0.00433	CcSEcCtD
Lincomycin—Vomiting—Vemurafenib—skin cancer	0.00431	0.00431	CcSEcCtD
Lincomycin—Rash—Vemurafenib—skin cancer	0.00428	0.00428	CcSEcCtD
Lincomycin—Dermatitis—Vemurafenib—skin cancer	0.00427	0.00427	CcSEcCtD
Lincomycin—Hypersensitivity—Imiquimod—skin cancer	0.00426	0.00426	CcSEcCtD
Lincomycin—Leukopenia—Dactinomycin—skin cancer	0.00421	0.00421	CcSEcCtD
Lincomycin—Anaphylactic shock—Bleomycin—skin cancer	0.00411	0.00411	CcSEcCtD
Lincomycin—Pruritus—Imiquimod—skin cancer	0.00409	0.00409	CcSEcCtD
Lincomycin—Nausea—Vemurafenib—skin cancer	0.00403	0.00403	CcSEcCtD
Lincomycin—Diarrhoea—Imiquimod—skin cancer	0.00396	0.00396	CcSEcCtD
Lincomycin—Angioedema—Temozolomide—skin cancer	0.00388	0.00388	CcSEcCtD
Lincomycin—Pancytopenia—Docetaxel—skin cancer	0.00385	0.00385	CcSEcCtD
Lincomycin—Hypotension—Bleomycin—skin cancer	0.00384	0.00384	CcSEcCtD
Lincomycin—Vertigo—Temozolomide—skin cancer	0.00382	0.00382	CcSEcCtD
Lincomycin—Leukopenia—Temozolomide—skin cancer	0.0038	0.0038	CcSEcCtD
Lincomycin—Neutropenia—Docetaxel—skin cancer	0.00379	0.00379	CcSEcCtD
Lincomycin—Vomiting—Imiquimod—skin cancer	0.00368	0.00368	CcSEcCtD
Lincomycin—Rash—Imiquimod—skin cancer	0.00365	0.00365	CcSEcCtD
Lincomycin—Dermatitis—Imiquimod—skin cancer	0.00365	0.00365	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.00358	0.00358	CcSEcCtD
Lincomycin—Jaundice—Docetaxel—skin cancer	0.00352	0.00352	CcSEcCtD
Lincomycin—Stomatitis—Docetaxel—skin cancer	0.00352	0.00352	CcSEcCtD
Lincomycin—Pain—Bleomycin—skin cancer	0.00352	0.00352	CcSEcCtD
Lincomycin—Leukopenia—Fluorouracil—skin cancer	0.0035	0.0035	CcSEcCtD
Lincomycin—Anaphylactic shock—Temozolomide—skin cancer	0.00347	0.00347	CcSEcCtD
Lincomycin—Nausea—Imiquimod—skin cancer	0.00344	0.00344	CcSEcCtD
Lincomycin—Agranulocytosis—Docetaxel—skin cancer	0.00337	0.00337	CcSEcCtD
Lincomycin—Pain—Dactinomycin—skin cancer	0.00328	0.00328	CcSEcCtD
Lincomycin—Urticaria—Bleomycin—skin cancer	0.00327	0.00327	CcSEcCtD
Lincomycin—Body temperature increased—Bleomycin—skin cancer	0.00325	0.00325	CcSEcCtD
Lincomycin—Anaphylactic shock—Fluorouracil—skin cancer	0.0032	0.0032	CcSEcCtD
Lincomycin—Erythema multiforme—Docetaxel—skin cancer	0.00307	0.00307	CcSEcCtD
Lincomycin—Body temperature increased—Dactinomycin—skin cancer	0.00303	0.00303	CcSEcCtD
Lincomycin—Abdominal pain—Dactinomycin—skin cancer	0.00303	0.00303	CcSEcCtD
Lincomycin—Hypersensitivity—Bleomycin—skin cancer	0.00303	0.00303	CcSEcCtD
Lincomycin—Hypotension—Fluorouracil—skin cancer	0.00299	0.00299	CcSEcCtD
Lincomycin—Pain—Temozolomide—skin cancer	0.00297	0.00297	CcSEcCtD
Lincomycin—Pruritus—Bleomycin—skin cancer	0.00291	0.00291	CcSEcCtD
Lincomycin—Hypersensitivity—Dactinomycin—skin cancer	0.00282	0.00282	CcSEcCtD
Lincomycin—Urticaria—Temozolomide—skin cancer	0.00275	0.00275	CcSEcCtD
Lincomycin—Body temperature increased—Temozolomide—skin cancer	0.00274	0.00274	CcSEcCtD
Lincomycin—Abdominal pain—Temozolomide—skin cancer	0.00274	0.00274	CcSEcCtD
Lincomycin—Pain—Fluorouracil—skin cancer	0.00273	0.00273	CcSEcCtD
Lincomycin—Diarrhoea—Dactinomycin—skin cancer	0.00262	0.00262	CcSEcCtD
Lincomycin—Vomiting—Bleomycin—skin cancer	0.00261	0.00261	CcSEcCtD
Lincomycin—Rash—Bleomycin—skin cancer	0.00259	0.00259	CcSEcCtD
Lincomycin—Dermatitis—Bleomycin—skin cancer	0.00259	0.00259	CcSEcCtD
Lincomycin—Hypersensitivity—Temozolomide—skin cancer	0.00255	0.00255	CcSEcCtD
Lincomycin—Urticaria—Fluorouracil—skin cancer	0.00254	0.00254	CcSEcCtD
Lincomycin—Leukopenia—Docetaxel—skin cancer	0.00253	0.00253	CcSEcCtD
Lincomycin—Body temperature increased—Fluorouracil—skin cancer	0.00253	0.00253	CcSEcCtD
Lincomycin—Pruritus—Temozolomide—skin cancer	0.00245	0.00245	CcSEcCtD
Lincomycin—Nausea—Bleomycin—skin cancer	0.00244	0.00244	CcSEcCtD
Lincomycin—Vomiting—Dactinomycin—skin cancer	0.00244	0.00244	CcSEcCtD
Lincomycin—Rash—Dactinomycin—skin cancer	0.00242	0.00242	CcSEcCtD
Lincomycin—Diarrhoea—Temozolomide—skin cancer	0.00237	0.00237	CcSEcCtD
Lincomycin—Hypersensitivity—Fluorouracil—skin cancer	0.00235	0.00235	CcSEcCtD
Lincomycin—Anaphylactic shock—Docetaxel—skin cancer	0.00231	0.00231	CcSEcCtD
Lincomycin—Nausea—Dactinomycin—skin cancer	0.00228	0.00228	CcSEcCtD
Lincomycin—Shock—Docetaxel—skin cancer	0.00227	0.00227	CcSEcCtD
Lincomycin—Pruritus—Fluorouracil—skin cancer	0.00226	0.00226	CcSEcCtD
Lincomycin—Vomiting—Temozolomide—skin cancer	0.0022	0.0022	CcSEcCtD
Lincomycin—Rash—Temozolomide—skin cancer	0.00219	0.00219	CcSEcCtD
Lincomycin—Diarrhoea—Fluorouracil—skin cancer	0.00219	0.00219	CcSEcCtD
Lincomycin—Dermatitis—Temozolomide—skin cancer	0.00218	0.00218	CcSEcCtD
Lincomycin—Hypotension—Docetaxel—skin cancer	0.00215	0.00215	CcSEcCtD
Lincomycin—Nausea—Temozolomide—skin cancer	0.00206	0.00206	CcSEcCtD
Lincomycin—Vomiting—Fluorouracil—skin cancer	0.00203	0.00203	CcSEcCtD
Lincomycin—Rash—Fluorouracil—skin cancer	0.00201	0.00201	CcSEcCtD
Lincomycin—Dermatitis—Fluorouracil—skin cancer	0.00201	0.00201	CcSEcCtD
Lincomycin—Pain—Docetaxel—skin cancer	0.00197	0.00197	CcSEcCtD
Lincomycin—Nausea—Fluorouracil—skin cancer	0.0019	0.0019	CcSEcCtD
Lincomycin—Abdominal pain—Docetaxel—skin cancer	0.00182	0.00182	CcSEcCtD
Lincomycin—Body temperature increased—Docetaxel—skin cancer	0.00182	0.00182	CcSEcCtD
Lincomycin—Hypersensitivity—Docetaxel—skin cancer	0.0017	0.0017	CcSEcCtD
Lincomycin—Pruritus—Docetaxel—skin cancer	0.00163	0.00163	CcSEcCtD
Lincomycin—Diarrhoea—Docetaxel—skin cancer	0.00158	0.00158	CcSEcCtD
Lincomycin—Vomiting—Docetaxel—skin cancer	0.00147	0.00147	CcSEcCtD
Lincomycin—Rash—Docetaxel—skin cancer	0.00145	0.00145	CcSEcCtD
Lincomycin—Dermatitis—Docetaxel—skin cancer	0.00145	0.00145	CcSEcCtD
Lincomycin—Nausea—Docetaxel—skin cancer	0.00137	0.00137	CcSEcCtD
